Trial Profile
Metformin therapy to prohibit progression in patients with abdominal aortic aneurysm
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2019
Price :
$35
*
At a glance
- Drugs Metformin (Primary)
- Indications Abdominal aortic aneurysm
- Focus Therapeutic Use
- Acronyms METAAA
- 17 Sep 2018 New trial record